NCT04111614View on ClinicalTrials.gov

A Study to Demonstrate the Equivalence of the Tofacitinib Oral Solution to the Tablet Formulation in Healthy Participants.

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 11, 2019

Primary Completion Date

December 12, 2019

Study Completion Date

December 12, 2019

Conditions
Healthy
Interventions
DRUG

Tofacitinib tablet

Single dose of tofacitinib 5 mg tablet

DRUG

Tofacitinib Oral Solution

Single 5 mL dose of tofacitinib oral solution (1 mg/mL)

Trial Locations (1)

06511

New Haven Clinical Research Unit, New Haven

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT04111614 - A Study to Demonstrate the Equivalence of the Tofacitinib Oral Solution to the Tablet Formulation in Healthy Participants. | Biotech Hunter | Biotech Hunter